Literature DB >> 9581179

[Prevention and therapy of acute radiation-related morbidity of the skin and mucosa. II, Recommendations of the literature].

J S Zimmermann1, P Niehoff, R Wilhelm, R Schneider, G Kovács, B Kimmig.   

Abstract

BACKGROUND: In a German multicenter questionnaire, answered by 89 departments, we had examined the strategies to prevent or to treat the acute morbidity of the skin and mucosa associated to radiation therapy. In this work, the recommendations from the literature are compared to the results of the questionnaire.
METHODS: An extensive research on common data information systems (Medline, Cancerlit, DIMDI and others) was performed. The criteria included the organ related morbidity and therapeutic strategies for its reduction. The obtained data were compared to the results from the questionnaire.
RESULTS: The study data found by the research often demonstrate small patient numbers and little convincing results. However, as in the questionnaire, the joint principle seems to be the reduction of acute inflammatory tissue reaction by evasion of bacterial and mycotic overgrowth and reduction of exo- and endogenous toxins.
CONCLUSIONS: Further studies with more convincing results are required.

Entities:  

Mesh:

Year:  1998        PMID: 9581179     DOI: 10.1007/BF03038526

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  98 in total

1.  [Etiology, prevention and therapy of early radiation reactions of the bladder and intestine].

Authors:  K A HUTER; H G MULLER
Journal:  Strahlentherapie       Date:  1958-11

2.  Beneficial effects of sucralphate in radiation induced diarrhea. An open randomized study in gynecological cancer patients.

Authors:  R Henriksson; M Arevärn; L Franzén; H Persson; U Stendahl
Journal:  Eur J Gynaecol Oncol       Date:  1990       Impact factor: 0.196

Review 3.  Cancer therapy, vomiting, and antiemetics.

Authors:  D J Stewart
Journal:  Can J Physiol Pharmacol       Date:  1990-02       Impact factor: 2.273

4.  A clinical trial evaluating cholestyramine to prevent diarrhea in patients maintained on low-fat diets during pelvic radiation therapy.

Authors:  S Chary; D H Thomson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1984-10       Impact factor: 7.038

5.  Effects of zacopride and BMY25801 (batanopride) on radiation-induced emesis and locomotor behavior in the ferret.

Authors:  G L King; M R Landauer
Journal:  J Pharmacol Exp Ther       Date:  1990-06       Impact factor: 4.030

6.  Benzydamine HCl, a new agent for the treatment of radiation mucositis of the oropharynx.

Authors:  J H Kim; F C Chu; V Lakshmi; R Houde
Journal:  Am J Clin Oncol       Date:  1986-04       Impact factor: 2.339

Review 7.  Gastrointestinal motility disorders and bacterial overgrowth.

Authors:  E Husebye
Journal:  J Intern Med       Date:  1995-04       Impact factor: 8.989

8.  Prophylaxis of radiation dermatitis with a topical cortisone cream.

Authors:  M E Potera; D P Lookingbill; J A Stryker
Journal:  Radiology       Date:  1982-06       Impact factor: 11.105

9.  Prophylactic administration of indomethacin for irradiation esophagitis.

Authors:  N Nicolopoulos; A Mantidis; E Stathopoulos; S Papaodysseas; J Kouvaris; H Varveris; C Papavasiliou
Journal:  Radiother Oncol       Date:  1985-01       Impact factor: 6.280

10.  Acute effects of abdominopelvic irradiation on the orocecal transit time: its relation to clinical symptoms, and bile salt and lactose malabsorption.

Authors:  F Fernández-Bañares; S Villá; M Esteve; M Roca; E Cabré; A Abad-Lacruz; J Martín-Comín; M A Gassull
Journal:  Am J Gastroenterol       Date:  1991-12       Impact factor: 10.864

View more
  2 in total

1.  [Prevention and therapy of acute radiation injuries of the skin and mucosa. I. Results of a German multicenter questionnaire].

Authors:  J S Zimmermann; R Wilhelm; P Niehoff; R Schneider; G Kovács; B Kimmig
Journal:  Strahlenther Onkol       Date:  1998-03       Impact factor: 3.621

2.  Amphotericin B lozengers: prophylaxis for esophagitis in thoracic radiotherapy: a prospective study.

Authors:  Karl Wurstbauer; Florian Merz; Felix Sedlmayer
Journal:  Strahlenther Onkol       Date:  2009-08-04       Impact factor: 3.621

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.